Yuji Miura, Genitourinary Medical Oncologist at Cancer Institute Hospital of JFCR, shared on X:
“Presidential Symposium III: RPIII Trial from China on Ris-Rez vs GD for Relapsed Osteosarcoma. PFS HR 0.33 and outstanding results!
However, mPFS 5.5 months and still a harsh reality.”
You can also read:
